{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:07Z","timestamp":1792784227062,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773331"],"award-info":[{"award-number":["81773331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Initiative for Innovative Medicine","doi-asserted-by":"crossref","award":["2017-12M-3-020"],"award-info":[{"award-number":["2017-12M-3-020"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The National Key Research and Development Program of China","award":["2016YFC0901500"],"award-info":[{"award-number":["2016YFC0901500"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.molimm.2020.07.016","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T12:48:55Z","timestamp":1597150135000},"page":"95-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Role of B cells in immune-mediated dermatoses"],"prefix":"10.1016","volume":"126","author":[{"given":"Wen-Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.molimm.2020.07.016_bib0005","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2017.07.012","article-title":"Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab","volume":"77","author":"Albers","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.molimm.2020.07.016_bib0010","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1038\/ncomms11724","article-title":"NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells","volume":"7","author":"Alrefai","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.molimm.2020.07.016_bib0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2133.2006.07305.x","article-title":"Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris","volume":"155","author":"Asashima","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"1\u20132","key":"10.1016\/j.molimm.2020.07.016_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","article-title":"The expression of BAFF in the muscles of patients with dermatomyositis","volume":"249","author":"Baek","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.molimm.2020.07.016_bib0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Bagci","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0030","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1038\/s41598-019-40203-7","article-title":"B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid","volume":"9","author":"Berkani","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"9997","key":"10.1016\/j.molimm.2020.07.016_bib0040","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.molimm.2020.07.016_bib0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clindermatol.2018.04.003","article-title":"Tsankov N. Dermatomyositis: current concepts","volume":"36","author":"Bogdanov","year":"2018","journal-title":"Clin. Dermatol."},{"issue":"5","key":"10.1016\/j.molimm.2020.07.016_bib0050","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.jaad.2010.08.007","article-title":"Treatment of psoriasis with rituximab","volume":"66","author":"Chang","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"175","key":"10.1016\/j.molimm.2020.07.016_bib0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.12335","article-title":"Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment","volume":"177","author":"Conigliaro","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2015.08.027","article-title":"Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis","volume":"137","author":"Czarnowicki","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaci.2016.09.060","article-title":"Alterations in B-cell subsets in pediatric patients with early atopic dermatitis","volume":"140","author":"Czarnowicki","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.molimm.2020.07.016_bib0075","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/art.22811","article-title":"Development of psoriasis after B cell depletion with rituximab","volume":"56","author":"Dass","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.molimm.2020.07.016_bib0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/ar2780","article-title":"B cells in autoimmunity","volume":"11","author":"Dorner","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.molimm.2020.07.016_bib0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ad.2012.10.022","article-title":"Bullous pemphigoid: clinical practice guidelines","volume":"105","author":"Fuertes de Vega","year":"2014","journal-title":"Actas Dermosifiliogr."},{"issue":"3","key":"10.1016\/j.molimm.2020.07.016_bib0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","article-title":"Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies","volume":"66","author":"Furue","year":"2017","journal-title":"Allergol. Int."},{"issue":"12","key":"10.1016\/j.molimm.2020.07.016_bib0095","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1038\/jid.2013.236","article-title":"Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients","volume":"133","author":"Hall","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.molimm.2020.07.016_bib0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2015.11.003","article-title":"IL-10-producing regulatory B cells are decreased in patients with psoriasis","volume":"81","author":"Hayashi","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.molimm.2020.07.016_bib0105","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3389\/fimmu.2019.01794","article-title":"Modifications of the transcriptomic profile of autoreactive B cells from pemphigus patients after treatment with rituximab or a standard corticosteroid regimen","volume":"10","author":"Hebert","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2020.07.016_bib0110","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1136\/annrheumdis-2012-201897","article-title":"Rituximab in psoriatic arthritis: an exploratory evaluation","volume":"71","author":"Jimenez-Boj","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.molimm.2020.07.016_bib0115","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/bjd.15113","article-title":"Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid","volume":"176","author":"Kabuto","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.molimm.2020.07.016_bib0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2340\/00015555-3069","article-title":"Aberrant B-cell subsets and immunoglobulin levels in patients with moderate-to-severe psoriasis","volume":"99","author":"Kahlert","year":"2019","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.molimm.2020.07.016_bib0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.molimm.2020.07.016_bib0130","article-title":"Impaired function of CD5+CD19+CD1dhi B10 cells on IgE secretion in an atopic dermatitis-like mouse model","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.07.016_bib0135","doi-asserted-by":"crossref","first-page":"27479","DOI":"10.1038\/srep27479","article-title":"Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41598-018-19226-z","article-title":"Dysfunction of CD19(+)CD24(hi)CD27(+) B regulatory cells in patients with bullous pemphigoid","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.molimm.2020.07.016_bib0145","doi-asserted-by":"crossref","first-page":"e5374","DOI":"10.1590\/1414-431x20165374","article-title":"CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity","volume":"49","author":"Lu","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"6","key":"10.1016\/j.molimm.2020.07.016_bib0150","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2020.07.016_bib0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2020.07.016_bib0160","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2020.07.016_bib0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2017.04.010","article-title":"IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNgamma-producing T cells","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2020.07.016_bib0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.det.2017.02.012","article-title":"Atopic dermatitis: racial and ethnic differences","volume":"35","author":"Mei-Yen Yong","year":"2017","journal-title":"Dermatol. Clin."},{"issue":"4","key":"10.1016\/j.molimm.2020.07.016_bib0175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4103\/ijdvl.IJDVL_96_16","article-title":"High B-cell-activating factor levels in endemic Tunisian pemphigus","volume":"83","author":"Mejri","year":"2017","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"9","key":"10.1016\/j.molimm.2020.07.016_bib0180","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/jdv.13027","article-title":"Increased circulating follicular helper T cells and activated B cells correlate with disease severity in patients with psoriasis","volume":"29","author":"Niu","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.molimm.2020.07.016_bib0185","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2020.07.016_bib0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2017.09.002","article-title":"Plan B (-cell) in atherosclerosis","volume":"816","author":"Nus","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2019.03.049","article-title":"Rituximab therapy in patients with bullous pemphigoid: a retrospective study of 20 patients","volume":"81","author":"Polansky","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.molimm.2020.07.016_bib0200","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3389\/fimmu.2019.01375","article-title":"Identification of autoreactive B cell subpopulations in peripheral blood of autoimmune patients with pemphigus vulgaris","volume":"10","author":"Pollmann","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.molimm.2020.07.016_bib0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/exd.12421","article-title":"B-cell activating factor detected on both naive and memory B cells in bullous pemphigoid","volume":"23","author":"Qian","year":"2014","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.molimm.2020.07.016_bib0210","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.molimm.2020.07.016_bib0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03009742.2018.1530371","article-title":"Peripheral blood lymphocyte subset repertoires are biased and reflect clinical features in patients with dermatomyositis","volume":"48","author":"Sasaki","year":"2019","journal-title":"Scand. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.molimm.2020.07.016_bib0220","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2008.03.007","article-title":"Anti-CD20 (rituximab) treatment for atopic eczema","volume":"121","author":"Sediva","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"34","key":"10.1016\/j.molimm.2020.07.016_bib0225","doi-asserted-by":"crossref","first-page":"55828","DOI":"10.18632\/oncotarget.10094","article-title":"Positive and negative functions of B lymphocytes in tumors","volume":"7","author":"Shen","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.molimm.2020.07.016_bib0230","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.clindermatol.2017.03.007","article-title":"Typical and atypical clinical appearance of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaci.2007.11.016","article-title":"Anti-CD20 (rituximab) treatment improves atopic eczema","volume":"121","author":"Simon","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2020.07.016_bib0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2009.10.002","article-title":"From atopic dermatitis to asthma: the atopic march","volume":"105","author":"Spergel","year":"2010","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2020.07.016_bib0245","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.celrep.2015.09.070","article-title":"Transcriptomics identify CD9 as a marker of murine IL-10-Competent regulatory B cells","volume":"13","author":"Sun","year":"2015","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0366-6999.221269","article-title":"Skin microbiome: an actor in the pathogenesis of psoriasis","volume":"131","author":"Wang","year":"2018","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.molimm.2020.07.016_bib0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/exd.13857","article-title":"Exosomes in chronic inflammatory skin diseases and skin tumors","volume":"28","author":"Wang","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"1 Pt 1","key":"10.1016\/j.molimm.2020.07.016_bib0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","article-title":"Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood","volume":"103","author":"Williams","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2020.07.016_bib0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pcl.2013.11.002","article-title":"Atopic dermatitis","volume":"61","author":"Wolter","year":"2014","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.molimm.2020.07.016_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2017.02.004","article-title":"Regulatory B cells: phenotype, function and role in transplantation","volume":"41","author":"Wortel","year":"2017","journal-title":"Transpl. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2020.07.016_bib0275","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1189\/jlb.1112562","article-title":"Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation","volume":"94","author":"Yanaba","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.molimm.2020.07.016_bib0280","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ajpath.2013.02.042","article-title":"CD19 expression in B cells regulates atopic dermatitis in a mouse model","volume":"182","author":"Yanaba","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.molimm.2020.07.016_bib0285","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jid.2017.05.032","article-title":"Pivotal role of Lesional and perilesional T\/B lymphocytes in pemphigus pathogenesis","volume":"137","author":"Yuan","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","article-title":"Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus","volume":"166","author":"Zhang","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2020.07.016_bib0295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/bjd.13192","article-title":"Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus","volume":"172","author":"Zhu","year":"2015","journal-title":"Br. J. Dermatol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020304314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020304314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:36:02Z","timestamp":1758980162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589020304314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":59,"alternative-id":["S0161589020304314"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.07.016","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of B cells in immune-mediated dermatoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}